1. Johson & Johnson is embarking on a two-year restructuring process of its orthopedic business after its third quarter earnings report reflected a shortfall in medical device sales.
2. Johnson & Johnson posted increases in third quarter revenue and orthopedic sales.
3. DePuy Synthes, Johnson and Johnson’s orthopedic company, earned FDA 510(k) clearance for the TriALTIS spine system.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
